Evidence map›Paper›PMID 33994886›Full record

ArticleContrast media & molecular imaging2021

Preliminary Study on the Clinical Significance and Methods of Using Carbon Nanoparticles in Endoscopic Papillary Thyroid Cancer Surgery.

Shangrui Rao, Zhonglin Wang, Congtao Pan, Yi Wang, Zhe Lin, Zhongliang Pan, Jian Yu

Open access · hybridAbstract read
In one paragraph

Article in Contrast media & molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shangrui RaoDepartment of General Surgery, Wenzhou Central Hospital, Wenzhou 325000, Zhejiang, China.
Zhonglin WangDepartment of General Surgery, Wenzhou Central Hospital, Wenzhou 325000, Zhejiang, China.
Congtao PanDepartment of General Surgery, Wenzhou Central Hospital, Wenzhou 325000, Zhejiang, China.
Yi WangDepartment of General Surgery, Wenzhou Central Hospital, Wenzhou 325000, Zhejiang, China.
Zhe LinDepartment of General Surgery, Wenzhou Central Hospital, Wenzhou 325000, Zhejiang, China.
Zhongliang PanDepartment of General Surgery, Wenzhou Central Hospital, Wenzhou 325000, Zhejiang, China.
Jian YuDepartment of General Surgery, Wenzhou Central Hospital, Wenzhou 325000, Zhejiang, China.ORCID 0000-0002-4538-1666
Wenzhou Central Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: The purpose of this study was to find the clinical significance and methods of using CN in endoscopic treatment for PTC. Materials and Methods: A total of 108 cases were randomly enrolled and divided into two groups, with 50 cases in the CN injection group who were injected with CN and 58 cases in the control group with no CN injection. All cases were analyzed with the size of carcinoma, the number of lymph node, and parathyroid gland injury. Results: All operations were successfully completed. The lymph node dissection number was 274 for the control group and 322 (the rate of black stained was 87%) for the CN injection group. The average number of lymph nodes in the CN injection group was 6.44 ± 2.08, which was significantly higher than that in the control group (4.72 ± 1.89). The control group had a relatively higher incidence of incidental parathyroidectomy, compared to the CN injection group (27.6% in the control group vs. 12% in the CN injection group, Conclusion: Using CN in endoscopic PTC surgery could increase the detection rate of lymph nodes and reduce the injury of parathyroid glands to a certain extent.

Indexed as

AdultCarbonEndoscopyFemaleHumansLymph Node ExcisionLymph NodesMaleMiddle AgedNanoparticlesParathyroid GlandsThyroid Cancer, PapillaryCarbon

Identifiers

PMID33994886
PMCPMC8096569
OpenAlexW3158518762

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.